世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034488

クロストリジウム診断の世界市場(2023-2027)

TechNavio

Global Clostridium Diagnostics Market 2023-2027

発刊日 2023/02/16

言語英語

体裁PDF/190ページ

ライセンス/価格190ページ

0000034488

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、クロストリジウム診断市場を分析します。

世界のクロストリジウム診断市場は、予測期間中に約13.69 %のCAGRで拡大し、2022年から2027年の間に21億4,840万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、CDI(クロストリディオイデス・ディフィシル感染症)の有病率の増加、高齢化社会の到来、新規治療法の開発によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 技術別
      ◇ イムノアッセイ
      ◇ 分子診断
    ➣ 製品別
      ◇ クロストリジウム・ディフィシル
      ◇ ウェルシュ菌
      ◇ ボツリヌス菌
      ◇ 破傷風菌
      ◇ クロストリジウム・ソルデリ
    ➣ エンドユーザー別
      ◇ 病院
      ◇ 独立研究所
      ◇ 診療所
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、今後数年間におけるクロストリジウム診断市場の成長を促進する主要な理由の一つとして、新たなワクチンの開発を挙げています。また、ワクチン研究へのイムノインフォマティクスの利用拡大や研究開発への高い投資も、市場の大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • クロストリジウム診断の市場規模
  • クロストリジウム診断の市場予測
  • クロストリジウム診断市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なクロストリジウム診断市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ AstraZeneca Plc
    ➣ Beckman Coulter Inc.
    ➣ Becton Dickinson and Co.
    ➣ bioMerieux SA
    ➣ DiaSorin SpA
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Ferring BV
    ➣ Fujirebio Holdings Inc.
    ➣ Hologic Inc.
    ➣ Huvepharma
    ➣ Meridian Bioscience Inc.
    ➣ Novartis AG
    ➣ オリンパス(Olympus Corp.)
    ➣ Pfizer Inc.
    ➣ QIAGEN NV
    ➣ Siemens AG
    ➣ Summit Therapeutics Inc.
    ➣ TECHLAB Inc.
    ➣ Thermo Fisher Scientific Inc.
    ➣ Trinity Biotech Plc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 08: Executive Summary - Chart on Incremental Growth
Exhibit 09: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 11: Parent market
Exhibit 12: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 13: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 14: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global clostridium diagnostics market 2017 - 2021
Exhibit 19: Historic Market Size - Data Table on Global clostridium diagnostics market 2017 - 2021 ($ million)
4.2 Technology Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 End user Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - End user Segment 2017 - 2021 ($ million)
4.5 Geography Segment Analysis 2017 - 2021
Exhibit 23: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.6 Country Segment Analysis 2017 - 2021
Exhibit 24: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 26: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 27: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 28: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 29: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 30: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technology
6.1 Market segments
Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)
6.2 Comparison by Technology
Exhibit 34: Chart on Comparison by Technology
Exhibit 35: Data Table on Comparison by Technology
6.3 Immunoassays - Market size and forecast 2022-2027
Exhibit 36: Chart on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibit 37: Data Table on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibit 38: Chart on Immunoassays - Year-over-year growth 2022-2027 (%)
Exhibit 39: Data Table on Immunoassays - Year-over-year growth 2022-2027 (%)
6.4 Molecular diagnostics - Market size and forecast 2022-2027
Exhibit 40: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 41: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 42: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 43: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Technology
Exhibit 44: Market opportunity by Technology ($ million)
Exhibit 45: Data Table on Market opportunity by Technology ($ million)

7 Market Segmentation by Product
7.1 Market segments
Exhibit 46: Chart on Product - Market share 2022-2027 (%)
Exhibit 47: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 48: Chart on Comparison by Product
Exhibit 49: Data Table on Comparison by Product
7.3 Clostridium difficile - Market size and forecast 2022-2027
Exhibit 50: Chart on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Clostridium difficile - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Clostridium difficile - Year-over-year growth 2022-2027 (%)
7.4 Clostridium perfringens - Market size and forecast 2022-2027
Exhibit 54: Chart on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibit 55: Data Table on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Chart on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
Exhibit 57: Data Table on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
7.5 Clostridium botulinum - Market size and forecast 2022-2027
Exhibit 58: Chart on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibit 59: Data Table on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Chart on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
Exhibit 61: Data Table on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
7.6 Clostridium tetani - Market size and forecast 2022-2027
Exhibit 62: Chart on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Data Table on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Chart on Clostridium tetani - Year-over-year growth 2022-2027 (%)
Exhibit 65: Data Table on Clostridium tetani - Year-over-year growth 2022-2027 (%)
7.7 Clostridium sordellii - Market size and forecast 2022-2027
Exhibit 66: Chart on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Data Table on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Chart on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
Exhibit 69: Data Table on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Product
Exhibit 70: Market opportunity by Product ($ million)
Exhibit 71: Data Table on Market opportunity by Product ($ million)

8 Market Segmentation by End-user
8.1 Market segments
Exhibit 72: Chart on End-user - Market share 2022-2027 (%)
Exhibit 73: Data Table on End-user - Market share 2022-2027 (%)
8.2 Comparison by End-user
Exhibit 74: Chart on Comparison by End-user
Exhibit 75: Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2022-2027
Exhibit 76: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 79: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
8.4 Independent laboratories - Market size and forecast 2022-2027
Exhibit 80: Chart on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Data Table on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Chart on Independent laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 83: Data Table on Independent laboratories - Year-over-year growth 2022-2027 (%)
8.5 Physicians clinics - Market size and forecast 2022-2027
Exhibit 84: Chart on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Data Table on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Chart on Physicians clinics - Year-over-year growth 2022-2027 (%)
Exhibit 87: Data Table on Physicians clinics - Year-over-year growth 2022-2027 (%)
8.6 Market opportunity by End-user
Exhibit 88: Market opportunity by End-user ($ million)
Exhibit 89: Data Table on Market opportunity by End-user ($ million)

9 Customer Landscape
9.1 Customer landscape overview
Exhibit 90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape
10.1 Geographic segmentation
Exhibit 91: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 92: Data Table on Market share By Geographical Landscape 2022-2027 (%)
10.2 Geographic comparison
Exhibit 93: Chart on Geographic comparison
Exhibit 94: Data Table on Geographic comparison
10.3 North America - Market size and forecast 2022-2027
Exhibit 95: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on North America - Year-over-year growth 2022-2027 (%)
10.4 Europe - Market size and forecast 2022-2027
Exhibit 99: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Europe - Year-over-year growth 2022-2027 (%)
10.5 Asia - Market size and forecast 2022-2027
Exhibit 103: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Asia - Year-over-year growth 2022-2027 (%)
10.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 107: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
10.7 US - Market size and forecast 2022-2027
Exhibit 111: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2022-2027 (%)
10.8 Germany - Market size and forecast 2022-2027
Exhibit 115: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 116: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 117: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on Germany - Year-over-year growth 2022-2027 (%)
10.9 UK - Market size and forecast 2022-2027
Exhibit 119: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 120: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 121: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 122: Data Table on UK - Year-over-year growth 2022-2027 (%)
10.10 China - Market size and forecast 2022-2027
Exhibit 123: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 124: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 125: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 126: Data Table on China - Year-over-year growth 2022-2027 (%)
10.11 Canada - Market size and forecast 2022-2027
Exhibit 127: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 128: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 129: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 130: Data Table on Canada - Year-over-year growth 2022-2027 (%)
10.12 Market opportunity By Geographical Landscape
Exhibit 131: Market opportunity By Geographical Landscape ($ million)
Exhibit 132: Data Tables on Market opportunity By Geographical Landscape ($ million)

11 Drivers, Challenges, and Trends
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Exhibit 133: Impact of drivers and challenges in 2022 and 2027
11.4 Market trends

12 Vendor Landscape
12.1 Overview
12.2 Vendor landscape
Exhibit 134: Overview on Criticality of inputs and Factors of differentiation
12.3 Landscape disruption
Exhibit 135: Overview on factors of disruption
12.4 Industry risks
Exhibit 136: Impact of key risks on business

13 Vendor Analysis
13.1 Vendors covered
Exhibit 137: Vendors covered
13.2 Market positioning of vendors
Exhibit 138: Matrix on vendor position and classification
13.3 AstraZeneca Plc
Exhibit 139: AstraZeneca Plc - Overview
Exhibit 140: AstraZeneca Plc - Product / Service
Exhibit 141: AstraZeneca Plc - Key news
Exhibit 142: AstraZeneca Plc - Key offerings
13.4 Becton Dickinson and Co.
Exhibit 143: Becton Dickinson and Co. - Overview
Exhibit 144: Becton Dickinson and Co. - Business segments
Exhibit 145: Becton Dickinson and Co. - Key news
Exhibit 146: Becton Dickinson and Co. - Key offerings
Exhibit 147: Becton Dickinson and Co. - Segment focus
13.5 bioMerieux SA
Exhibit 148: bioMerieux SA - Overview
Exhibit 149: bioMerieux SA - Product / Service
Exhibit 150: bioMerieux SA - Key offerings
13.6 DiaSorin SpA
Exhibit 151: DiaSorin SpA - Overview
Exhibit 152: DiaSorin SpA - Business segments
Exhibit 153: DiaSorin SpA - Key news
Exhibit 154: DiaSorin SpA - Key offerings
Exhibit 155: DiaSorin SpA - Segment focus
13.7 F. Hoffmann La Roche Ltd.
Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
13.8 Ferring BV
Exhibit 161: Ferring BV - Overview
Exhibit 162: Ferring BV - Product / Service
Exhibit 163: Ferring BV - Key offerings
13.9 Fujirebio Holdings Inc.
Exhibit 164: Fujirebio Holdings Inc. - Overview
Exhibit 165: Fujirebio Holdings Inc. - Product / Service
Exhibit 166: Fujirebio Holdings Inc. - Key offerings
13.10 Hologic Inc.
Exhibit 167: Hologic Inc. - Overview
Exhibit 168: Hologic Inc. - Business segments
Exhibit 169: Hologic Inc. - Key news
Exhibit 170: Hologic Inc. - Key offerings
Exhibit 171: Hologic Inc. - Segment focus
13.11 Huvepharma
Exhibit 172: Huvepharma - Overview
Exhibit 173: Huvepharma - Product / Service
Exhibit 174: Huvepharma - Key offerings
13.12 Novartis AG
Exhibit 175: Novartis AG - Overview
Exhibit 176: Novartis AG - Business segments
Exhibit 177: Novartis AG - Key offerings
Exhibit 178: Novartis AG - Segment focus
13.13 Olympus Corp.
Exhibit 179: Olympus Corp. - Overview
Exhibit 180: Olympus Corp. - Business segments
Exhibit 181: Olympus Corp. - Key news
Exhibit 182: Olympus Corp. - Key offerings
Exhibit 183: Olympus Corp. - Segment focus
13.14 Pfizer Inc.
Exhibit 184: Pfizer Inc. - Overview
Exhibit 185: Pfizer Inc. - Product / Service
Exhibit 186: Pfizer Inc. - Key news
Exhibit 187: Pfizer Inc. - Key offerings
13.15 QIAGEN NV
Exhibit 188: QIAGEN NV - Overview
Exhibit 189: QIAGEN NV - Product / Service
Exhibit 190: QIAGEN NV - Key news
Exhibit 191: QIAGEN NV - Key offerings
13.16 Siemens AG
Exhibit 192: Siemens AG - Overview
Exhibit 193: Siemens AG - Business segments
Exhibit 194: Siemens AG - Key news
Exhibit 195: Siemens AG - Key offerings
Exhibit 196: Siemens AG - Segment focus
13.17 Thermo Fisher Scientific Inc.
Exhibit 197: Thermo Fisher Scientific Inc. - Overview
Exhibit 198: Thermo Fisher Scientific Inc. - Business segments
Exhibit 199: Thermo Fisher Scientific Inc. - Key news
Exhibit 200: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 201: Thermo Fisher Scientific Inc. - Segment focus

14 Appendix
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Exhibit 202: Inclusions checklist
Exhibit 203: Exclusions checklist
14.3 Currency conversion rates for US$
Exhibit 204: Currency conversion rates for US$
14.4 Research methodology
Exhibit 205: Research methodology
Exhibit 206: Validation techniques employed for market sizing
Exhibit 207: Information sources
14.5 List of abbreviations
Exhibit 208: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Vendor Market Positioning
Exhibits11: Parent market
Exhibits12: Market Characteristics
Exhibits13: Offerings of vendors included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits19: Historic Market Size - Data Table on Global clostridium diagnostics market 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - End user Segment 2017 - 2021 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits24: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits25: Five forces analysis - Comparison between 2022 and 2027
Exhibits26: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits28: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits29: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits30: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits31: Chart on Market condition - Five forces 2022 and 2027
Exhibits32: Chart on Technology - Market share 2022-2027 (%)
Exhibits33: Data Table on Technology - Market share 2022-2027 (%)
Exhibits34: Chart on Comparison by Technology
Exhibits35: Data Table on Comparison by Technology
Exhibits36: Chart on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibits37: Data Table on Immunoassays - Market size and forecast 2022-2027 ($ million)
Exhibits38: Chart on Immunoassays - Year-over-year growth 2022-2027 (%)
Exhibits39: Data Table on Immunoassays - Year-over-year growth 2022-2027 (%)
Exhibits40: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits41: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits42: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits43: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits44: Market opportunity by Technology ($ million)
Exhibits45: Data Table on Market opportunity by Technology ($ million)
Exhibits46: Chart on Product - Market share 2022-2027 (%)
Exhibits47: Data Table on Product - Market share 2022-2027 (%)
Exhibits48: Chart on Comparison by Product
Exhibits49: Data Table on Comparison by Product
Exhibits50: Chart on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Clostridium difficile - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Clostridium difficile - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Clostridium difficile - Year-over-year growth 2022-2027 (%)
Exhibits54: Chart on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibits55: Data Table on Clostridium perfringens - Market size and forecast 2022-2027 ($ million)
Exhibits56: Chart on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
Exhibits57: Data Table on Clostridium perfringens - Year-over-year growth 2022-2027 (%)
Exhibits58: Chart on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibits59: Data Table on Clostridium botulinum - Market size and forecast 2022-2027 ($ million)
Exhibits60: Chart on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
Exhibits61: Data Table on Clostridium botulinum - Year-over-year growth 2022-2027 (%)
Exhibits62: Chart on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibits63: Data Table on Clostridium tetani - Market size and forecast 2022-2027 ($ million)
Exhibits64: Chart on Clostridium tetani - Year-over-year growth 2022-2027 (%)
Exhibits65: Data Table on Clostridium tetani - Year-over-year growth 2022-2027 (%)
Exhibits66: Chart on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibits67: Data Table on Clostridium sordellii - Market size and forecast 2022-2027 ($ million)
Exhibits68: Chart on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
Exhibits69: Data Table on Clostridium sordellii - Year-over-year growth 2022-2027 (%)
Exhibits70: Market opportunity by Product ($ million)
Exhibits71: Data Table on Market opportunity by Product ($ million)
Exhibits72: Chart on End-user - Market share 2022-2027 (%)
Exhibits73: Data Table on End-user - Market share 2022-2027 (%)
Exhibits74: Chart on Comparison by End-user
Exhibits75: Data Table on Comparison by End-user
Exhibits76: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits77: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits78: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits80: Chart on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits81: Data Table on Independent laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits82: Chart on Independent laboratories - Year-over-year growth 2022-2027 (%)
Exhibits83: Data Table on Independent laboratories - Year-over-year growth 2022-2027 (%)
Exhibits84: Chart on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibits85: Data Table on Physicians clinics - Market size and forecast 2022-2027 ($ million)
Exhibits86: Chart on Physicians clinics - Year-over-year growth 2022-2027 (%)
Exhibits87: Data Table on Physicians clinics - Year-over-year growth 2022-2027 (%)
Exhibits88: Market opportunity by End-user ($ million)
Exhibits89: Data Table on Market opportunity by End-user ($ million)
Exhibits90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits91: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits92: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits93: Chart on Geographic comparison
Exhibits94: Data Table on Geographic comparison
Exhibits95: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits116: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits117: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits119: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits120: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits121: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits122: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits123: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits124: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits125: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits126: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits127: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits128: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits129: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits130: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits131: Market opportunity By Geographical Landscape ($ million)
Exhibits132: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits133: Impact of drivers and challenges in 2022 and 2027
Exhibits134: Overview on Criticality of inputs and Factors of differentiation
Exhibits135: Overview on factors of disruption
Exhibits136: Impact of key risks on business
Exhibits137: Vendors covered
Exhibits138: Matrix on vendor position and classification
Exhibits139: AstraZeneca Plc - Overview
Exhibits140: AstraZeneca Plc - Product / Service
Exhibits141: AstraZeneca Plc - Key news
Exhibits142: AstraZeneca Plc - Key offerings
Exhibits143: Becton Dickinson and Co. - Overview
Exhibits144: Becton Dickinson and Co. - Business segments
Exhibits145: Becton Dickinson and Co. - Key news
Exhibits146: Becton Dickinson and Co. - Key offerings
Exhibits147: Becton Dickinson and Co. - Segment focus
Exhibits148: bioMerieux SA - Overview
Exhibits149: bioMerieux SA - Product / Service
Exhibits150: bioMerieux SA - Key offerings
Exhibits151: DiaSorin SpA - Overview
Exhibits152: DiaSorin SpA - Business segments
Exhibits153: DiaSorin SpA - Key news
Exhibits154: DiaSorin SpA - Key offerings
Exhibits155: DiaSorin SpA - Segment focus
Exhibits156: F. Hoffmann La Roche Ltd. - Overview
Exhibits157: F. Hoffmann La Roche Ltd. - Business segments
Exhibits158: F. Hoffmann La Roche Ltd. - Key news
Exhibits159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits160: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits161: Ferring BV - Overview
Exhibits162: Ferring BV - Product / Service
Exhibits163: Ferring BV - Key offerings
Exhibits164: Fujirebio Holdings Inc. - Overview
Exhibits165: Fujirebio Holdings Inc. - Product / Service
Exhibits166: Fujirebio Holdings Inc. - Key offerings
Exhibits167: Hologic Inc. - Overview
Exhibits168: Hologic Inc. - Business segments
Exhibits169: Hologic Inc. - Key news
Exhibits170: Hologic Inc. - Key offerings
Exhibits171: Hologic Inc. - Segment focus
Exhibits172: Huvepharma - Overview
Exhibits173: Huvepharma - Product / Service
Exhibits174: Huvepharma - Key offerings
Exhibits175: Novartis AG - Overview
Exhibits176: Novartis AG - Business segments
Exhibits177: Novartis AG - Key offerings
Exhibits178: Novartis AG - Segment focus
Exhibits179: Olympus Corp. - Overview
Exhibits180: Olympus Corp. - Business segments
Exhibits181: Olympus Corp. - Key news
Exhibits182: Olympus Corp. - Key offerings
Exhibits183: Olympus Corp. - Segment focus
Exhibits184: Pfizer Inc. - Overview
Exhibits185: Pfizer Inc. - Product / Service
Exhibits186: Pfizer Inc. - Key news
Exhibits187: Pfizer Inc. - Key offerings
Exhibits188: QIAGEN NV - Overview
Exhibits189: QIAGEN NV - Product / Service
Exhibits190: QIAGEN NV - Key news
Exhibits191: QIAGEN NV - Key offerings
Exhibits192: Siemens AG - Overview
Exhibits193: Siemens AG - Business segments
Exhibits194: Siemens AG - Key news
Exhibits195: Siemens AG - Key offerings
Exhibits196: Siemens AG - Segment focus
Exhibits197: Thermo Fisher Scientific Inc. - Overview
Exhibits198: Thermo Fisher Scientific Inc. - Business segments
Exhibits199: Thermo Fisher Scientific Inc. - Key news
Exhibits200: Thermo Fisher Scientific Inc. - Key offerings
Exhibits201: Thermo Fisher Scientific Inc. - Segment focus
Exhibits202: Inclusions checklist
Exhibits203: Exclusions checklist
Exhibits204: Currency conversion rates for US$
Exhibits205: Research methodology
Exhibits206: Validation techniques employed for market sizing
Exhibits207: Information sources
Exhibits208: List of abbreviations

この商品のレポートナンバー

0000034488

TOP